Skip to content

A clinical study on KUROSANI OMAM CHOORANAM in the management of CEGANAVATHAM (cervical spondylosis)

A prospective open labelled non randomized phase II clinical trial on KUROSANI OMAM CHOORANAM in the management of CEGANAVATHAM (cervical spondylosis)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031098
Enrollment
60
Registered
2021-02-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M478- Other spondylosis

Interventions

Intervention1: KUROSANI OMAM CHOORANAM: 130-260mg/twice a day(orally) with honey A/F 45 days Control Intervention1: Nil: Nil

Sponsors

Government siddha medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Neck pain radiating to upper limb with or without numbness, giddiness and neck stiffness. Restriction neck movements. Willing for doing laboratory investigations and X-ray imaging. The neck disability index score should be equal or greater than 40%.

Exclusion criteria

Exclusion criteria: Age:less than 20;Greater than 60. Traumatic injury. Systemic hypertension. Ischemic heart disease. Chronic kidney disease. Tuberculosis in spine. Pregnancy and lactating women. Diabetes mellitus. Congenital spinal anomalies.

Design outcomes

Primary

MeasureTime frame
Reduction of the symptoms of pain in neck and upper limbs. Improvement of the range of movements in the neck and upper limbs. The outcome is aimed at reducing the pain and increasing the range of movements.Timepoint: 45 days

Secondary

MeasureTime frame
To evaluate physio chemical, phyto chemical, bio chemical analysis. To evaluate siddha parameters and compare the (including Envagai thervu) changes in ceganavatham during trial period. To evaluate safety profile for acute and subacute toxicity of trial drug. To study antimicrobial activity for selected microorganisms. Timepoint: 45 days

Countries

India

Contacts

Public ContactDr A Manoharan MDsPhD

Government siddha medical college and hospital

drmanoharan25@gmail.com9443886700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026